Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 24;13(1):152-158.
doi: 10.4103/idoj.idoj_573_21. eCollection 2022 Jan-Feb.

Amphotericin-B in Dermatology

Akash Agarwal  1 , Bikash R Kar  1
Affiliations

Amphotericin-B in Dermatology

Akash Agarwal et al. Indian Dermatol Online J. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Mechanism of action of Amphotericin B
See this image and copyright information in PMC

References

    1. Ravani SA, Agrawal GA, Leuva PA, Modi PH, Amin KD. Rise of the phoenix: Mucormycosis in COVID-19 times. Indian J Ophthalmol. 2021;69:1563–8. - PMC - PubMed
    1. Hamill RJ. Amphotericin B formulations: A comparative review of efficacy and toxicity. Drugs. 2013;73:919–34. - PubMed
    1. Steimbach LM, Tonin FS, Virtuoso S, Borba HH, Sanches AC, Wiens A, et al. Efficacy and safety of amphotericin B lipid-based formulations-A systematic review and meta-analysis. Mycoses. 2017;60:146–54. - PubMed
    1. Lanza JS, Pomel S, Loiseau PM, Frézard F. Recent advances in amphotericin B delivery strategies for the treatment of leishmaniases. Expert Opin Drug Deliv. 2019;16:1063–79. - PubMed
    1. World Health Organization Control of the Leishmaniases. 2010. [Last accessed on 2021 Jun 04]. Available from: http://whqlibdoc.who.int/trs/WHO_TRS_949_eng.pdf .